2026-06-24
Beyond the Limitations of Conventional SEC: Why SEC-MALS Has Become the Benchmark for Characterizing Complex Biologics
Why are an increasing number of ADC, membrane protein, and nucleic acid drug development programs beginning to adopt SEC-MALS?